Adjuvant immunotherapy for non-small cell lung cancer

Zachary C G Tucker1, Benjamin A Laguna, Edmund Moon

  • 1Division of Thoracic Surgery, University of Pennsylvania School of Medicine, 6 White, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, USA. ztucker@tcmedc.org

Cancer Treatment Reviews
|January 10, 2012
PubMed
Summary

Immunotherapy can help prevent non-small cell lung cancer (NSCLC) recurrence after surgery. This approach targets microscopic tumor cells, improving outcomes for patients with lung cancer.

Related Concept Videos